SUPERNUS PHARMACEUTICALS, INC.·4

Feb 21, 4:51 PM ET

Hudson Frederick M. 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 21, 2025

Insider Transaction Report

Form 4
Period: 2025-02-19
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2025-02-19+7,2967,296 total
    Exercise: $33.52Exp: 2035-02-19Common Stock (7,296 underlying)
  • Award

    Restricted Stock Unit

    2025-02-19+4,4754,475 total
    Common Stock (4,475 underlying)
Holdings
  • Common Stock

    48,395
Footnotes (3)
  • [F1]The option vests on February 19, 2026.
  • [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
  • [F3]These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026.

Documents

1 file
  • 4
    wk-form4_1740174702.xmlPrimary

    FORM 4